VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.

Akesson, Lina

VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. [electronic resource] - Endocrinology Feb 2005 - 744-50 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0013-7227

10.1210/en.2004-0504 doi


Adipocytes--drug effects
Animals
Cyclic AMP-Dependent Protein Kinase Type II
Cyclic AMP-Dependent Protein Kinases--metabolism
Gene Expression
Lipolysis--drug effects
Male
Nerve Growth Factors--metabolism
Neuropeptides--metabolism
Neurotransmitter Agents--metabolism
Peptide Fragments--pharmacology
Pituitary Adenylate Cyclase-Activating Polypeptide
Rats
Rats, Sprague-Dawley
Receptors, Cell Surface--antagonists & inhibitors
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
Receptors, Vasoactive Intestinal Peptide--agonists
Receptors, Vasoactive Intestinal Peptide, Type II
Receptors, Vasoactive Intestinal Polypeptide, Type I
Vasoactive Intestinal Peptide--metabolism